Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models
A. Petcherski, M. Sharma, S. Satta…·T. Kelesidis
Mitoquinone mesylate shows antiviral and anti-inflammatory effects against SARS-CoV-2 in preclinical models.
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
A. Petcherski, M. Sharma, S. Satta…·T. Kelesidis
Mitoquinone mesylate shows antiviral and anti-inflammatory effects against SARS-CoV-2 in preclinical models.
G. Carraro, J. Langerman, S. Sabri…·B. N. Gomperts
The paper uses single-cell transcriptomics to analyze proximal airway epithelium in CF and healthy donors, identifying molecular changes linked to CF pathogenesis.
A. Purkayastha, C. Sen, G. Garcia…·B. N. Gomperts
This study shows that cigarette smoke exposure increases SARS-CoV-2 infection severity in airway cultures by reducing interferon response and ABSC proliferation.
A. Mulay, B. Konda, G. Garcia…·B. Stripp
The paper develops a primary human lung epithelium infection model to study SARS-CoV-2 pathobiology and screen drugs for COVID-19.
G. Alterovitz, D. A. Dean, C. Goble…·R. Mazumder
The paper introduces the BioCompute framework to standardize genomic data reporting, enabling reproducibility and interoperability in precision medicine.